Research progress on risk of major adverse cardiovascular events associated with Janus kinase inhibitors in treatment of immune-mediated inflammatory diseases

Zhao Danjie, Bian Yuan, Yin Qi'nan, Wang Yi, Tang Peng, Han Lizhu

PDF(384 KB)
PDF(384 KB)
Adverse Drug Reactions Journal ›› 2025, Vol. 27 ›› Issue (1) : 44-49. DOI: 10.3760/cma.j.cn114015-20240513-00338

Research progress on risk of major adverse cardiovascular events associated with Janus kinase inhibitors in treatment of immune-mediated inflammatory diseases

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 27(1): 44-49 https://doi.org/10.3760/cma.j.cn114015-20240513-00338

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(384 KB)

Accesses

Citation

Detail

Sections
Recommended

/